Ypsomed Holding AG reported earnings results for the half year ended September 30, 2023. For the half year, the company reported net income was CHF 36.58 million compared to CHF 15.44 million a year ago. Basic earnings per share from continuing operations was CHF 2.68 compared to CHF 1.17 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
422 CHF | +1.32% |
|
+2.43% | +39.27% |
Jun. 20 | Ypsomed Partner Secures US FDA Nod for Automated Insulin Delivery Algorithm | MT |
Jun. 12 | German Pharmaceutical Medac Picks Ypsomed Autoinjector for Methotrexate Pen Relaunch | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.27% | 6.32B | |
-5.50% | 178B | |
-5.79% | 98.95B | |
-6.59% | 66.14B | |
-8.38% | 44.11B | |
+8.42% | 43.82B | |
+10.10% | 42.74B | |
+10.97% | 28.92B | |
+18.89% | 25.06B | |
-8.39% | 23.38B |
- Stock Market
- Equities
- YPSN Stock
- News Ypsomed Holding AG
- Ypsomed Holding AG Reports Earnings Results for the Half Year Ended September 30, 2023